A new report says the Massachusetts Department of Children and Families mismanaged mental health care for children. State ...

The state auditor report found poor record keeping and a lack of therapy to accompany psychotropic medications.

Presentations include results from two pivotal studies (Studies 501 and 502) evaluating lumateperone as an adjunctive therapy to antidepressants ...

Intra-Cellular Therapies’ atypical antipsychotic medication Caplyta has been on a roll, delivering fast commercial growth and coming up triumphant in yet another late-stage trial. | Intra-Cellular ...

Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the ...

Using data from linked Swedish health-related registries, researchers examined outpatient antipsychotic use and ...

1 Approximately 20% of people who take certain older antipsychotic medications may develop tardive dyskinesia; however, it is difficult to know how common tardive dyskinesia is because there aren ...

Table 5 describes in detail the medications received during the 30 days prior to NMS onset. Antipsychotic polypharmacy rates where high (7 cases, 53.8%), as was the use of parenteral medication (5 ...

Karuna led the charge developing a new class of antipsychotic medications, and was recently acquired through a $14 billion deal. In some ways, Seaport serves as Karuna’s successor. The biotech’s most ...